psoralidin

CAS: 18642-23-4

Ref. 3D-FP73918

Produktinformation

• Name: psoralidin
• Synonyme: 3,9-Dihydroxy-2-(3-methyl-2-buten-1-yl)-6H-benzofuro[3,2-c][1]benzopyran-6-one, 3,9-Dihydroxy-2-(3-methyl-2-butenyl)-6H-benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-Dihydroxy-2-(3-methylbut-2-enyl)-[1]benzofuro[3,2-c]chromen-6-one, 3,9-dihydroxy-2-(3-methylbut-2-en-1-yl)-6H-[1]benzofuro[3,2-c]chromen-6-one, 3-Benzofurancarboxylic acid, 2-[2,4-dihydroxy-5-(3-methyl-2-butenyl)phenyl]-6-hydroxy-, δ-lactone, 6H-Benzofuro(3,2-c)(1)benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-butenyl)-, 6H-Benzofuro[3,2-c][1]benzopyran-6-one, 3,9-dihydroxy-2-(3-methyl-2-buten-1-yl)-, Psoralidin

Beschreibung

Psoralidin is a pharmacological agent that induces apoptosis in cancer cells. It binds to the response element of the pro-apoptotic gene, PUMA, and causes the activation of several proteins involved in the apoptosis pathway. It has been shown to successfully induce cell death in HL-60 cells and murine hepatoma cells. Psoralidin is also able to inhibit cancer cell proliferation by suppressing the expression of oncogenes such as MMP-2, MMP-9, and COX-2. The mechanism by which psoralidin induces apoptosis is not yet fully understood but may be due to its ability to induce endoplasmic reticulum stress or activate caspases.

• Marke: Biosynth

Chemische Eigenschaften

• Reinheit: Min. 95%